Matt Hobbs

Real conclusion: evidence informed combination of tests will be needed and combination might not be the same for all!

Can targeted SBRT help men with oligoprogressive #prostatecancer avoid chemotherapy for longer?

Dr Priyanka Patel, @alison-tree.bsky.social & team at the Royal Marsden publish results of the @prostateuk.bsky.social funded TRAP trial in @ijrobp.bsky.social

Grab a ☕ & read: doi.org/10.1016/j.ij...

ICYMI last week, the NPCA's latest publication

"Are evidence-based guidelines translating into clinical practice? A national population-based study of the use of treatment intensification in metastatic hormone-sensitive prostate cancer (mHSPC) in England"

👉 www.ejcancer.com/action/showP...

⚠️Do you or someone you know want to come and work with me and the fantastic @npca-natcan.bsky.social @natcan-news.bsky.social teams based @collegeofsurgeons.bsky.social? Our oncological clinical lead is the super @alison-tree.bsky.social 😁.

Interested? Apply here www.jobs.ac.uk/job/DMB374/c...

‘Groundbreaking’ scan for men with prostate cancer could save lives Researchers hope the technology will help to create personalised treatment plans to prevent the disease becoming terminal

🚨 We're launching the £1.89M #IP13AVIDITY trial to test PSMA PET/CT scans for detecting & escalating #ProstateCancer treatment funded by @prostateuk.bsky.social

Co-led by @londonprostate1.bsky.social @connorurol.bsky.social #TaraBarwick #RhianGabe #AdamBrentnall

🗞️➡️ www.thetimes.com/uk/healthcar...

Stereotactic body radiotherapy for oligoprogressive disease in androgen suppressed prostate cancer: Primary endpoint analysis of the TRAP trial Optimal management of oligoprogressive prostate cancer whilst on androgen receptor pathway inhibitors (ARPi) is not known. The **** trial tests the ro…

TRAP trial results now out @ijrobp.bsky.social funded by @prostatecanceruk.bsky.social Men oligoprogressing on Abi/Enza for CRPC, nearly 40% progression-free 1 year after SBRT. No significant side effects due to radiotherapy.

www.sciencedirect.com/science/arti...

also flagging this @anzuptrials.bsky.social joint funding op for UK-Australian platform trials. Prostate cancer specifically called out. Happy for us (@prostateukprofs.bsky.social) to help if you want targeted intros to UK researchers www.nhmrc.gov.au/funding/find...

Dr Neil Ryan's story is just one example of the incredible research opportunities our Starter Grant for Clinical Lecturers scheme offers.

With just 2 weeks left, apply by 5 March 2025 to receive up to £30K to fund your research 🌟

👉 ow.ly/GWKu50V1Soh

#HealthResearch #Grants

PhD studentship in Prostate Cancer - Refining human prostate tissue culture techniques for better in vivo mimicry and therapeutic insights at Newcastle University on FindAPhD.com PhD Project - PhD studentship in Prostate Cancer - Refining human prostate tissue culture techniques for better in vivo mimicry and therapeutic insights at Newcastle University, listed on FindAPhD.com

PhD Position available in my lab. Interested in prostate cancer research and developing novel disease models to accelerate research impact then this is for you. Come and join of research community @nucancer.bsky.social
www.findaphd.com/phds/project...

Starter Grants for Clinical Lecturers We are working with The Academy of Medical Sciences to support Clinical Lecturers who are looking to develop and strengthen their research careers.

Are you a Clinical Lecturer looking to develop and strengthen your research career?

The @acmedsci.bsky.social Starter Grants provides £30k funding for up to 2 years.

Deadline: 5 March 2025.

Apply now 👇
prostatecanceruk.org/research/for...

#CareerDevelopment #ResearchFunding

Every week, I see a new study talking about this or that effect of GLP-1 receptor agonists like #ozempic. FINALLY, we have a study evaluating all the outcomes (good and bad) in one dataset. There are some... surprises. 🧵

🏃 Flying start to #IP9ATLAS - first 5️⃣0️⃣ patients recruited!

🔎 Comparing regular MRI scans to standard of care in patients with prostate cancer on active surveillance

🎉 Thank you to our site teams Imperial College Healthcare NHST, Dartford and Gravesham NHST & Frimley Health NHSFT

Great to see this @prostatecanceruk.bsky.social funded work published!

🥳 Congrats team @asharpmedonc.bsky.social & everyone from @icrlondon.bsky.social

#prostatecancer #research
🧬🧫🔬

This was particularly exciting for me as I was interviewed about the impact of the paper for radio #faceforradio

I spy two amazing bluesky-less candidates for the @AACR board of directors. Please consider Johann de Bono @ICR_London @royalmarsdenNHS and Timothy Yap @MDAndersonNews.
www.aacr.org/professional...

NXP800 activates the unfolded protein response, altering AR and E2F function to impact castration-resistant prostate cancer growth. Welti et al. (2025) Clinical Cancer Research.

Could targeting the Heat Shock Factor 1 (HSF1) pathway be a new avenue for treating hormone therapy-resistant #prostatecancer?

@asharpmedonc.bsky.social and the team @icrlondon.bsky.social share their exciting new findings.

Grab a ☕and read: doi.org/10.1158/1078...

The National Prostate Cancer Audit State of the Nation Report 2024 has been published! It is available here www.npca.org.uk/reports/npca... alongside its appendix, methodology supplement and data tables.

Seychelles - an extravagant Christmas celebrating a friend's (big) birthday. It was absolutely glorious start to finish! Warm for running but delightful for swimming!

The Thames is nice but I'm very much missing my Christmas and New Year water now I'm back... Hope you both had a good break!

I think that will help a lot. Thank you!

Hi bluesky prostate folk. Quick question - does anyone know of any papers where a cohort has had both NCCN and CPG prognostic levels assigned/calculated to see how much overlap and outlying there is? Thinking specifically in the intermediate risk groups if that helps.

I just helped save a life You can save one, too. Donate now.

My heart sank when I heard the news that Felix Feng has passed away. Felix was such a gentle and uplifting force for so many of us who work in the same field - and for anyone he touched. Although he has left us, his impact will be felt forever. ow.ly/Uc3H50TSBiC

Elucidating acquired PARP inhibitor resistance in advanced prostate cancer PARP inhibition (PARPi) has anti-tumor activity against castration-resistant prostate cancer (CRPC) with homologous recombination repair (HRR) defects…

Proud to see incredible work from @seedgeorge.bsky.social published - tracking PARP inhibitor resistance in prostate cancer in real-time through blood tests. Honored to contribute! @icrlondon.bsky.social 🧬 #medsky #science 🧪
Full paper: sciencedirect.com/science/article/pii/S1535610824004033

a man in a tie is making a funny face with his hands in the air and the words `` so excited ! '' ALT: a man in a tie is making a funny face with his hands in the air and the words `` so excited ! ''

Yesterday it was announced that the Research Impact Team @prostatecanceruk.bsky.social is going to become the Research Impact and Engagement Team!

My team will be expanding, so we'll have extra capacity to develop new ways to promote impact and engage with the research community

#excited

Action Intent Links | Bluesky Authors, websites, and apps can use action intent links to implement "Share on Bluesky" buttons, or similar in-app actions. Logged-in users will be directed to the corresponding action view in the Blu...

We strongly suggest that academic publishers and other platforms that host research rapidly implement a Share to Bluesky button for their articles. Here's how:

docs.bsky.app/docs/advance...

#AcademicSky #HigherEd #Altmetrics

🎨 In case anyone need…

The NIH BioArt Source is an awesome library of *free* professionally drawn illustrations for scientific presentations or figures. Downloadable in HD. Thank you NIH for this invaluable tool 🙏!

Check it out 👇
bioart.niaid.nih.gov

Scientists can predict how long prostate cancer patients will respond to olaparib Scientists have worked out a way of predicting how long a prostate cancer patient will continue to respond to the PARP inhibitor drug, olaparib, according to new research published in the journal Canc...

🆕 Scientists have worked out a way to predict how long #ProstateCancer patients will respond to the PARP inhibitor drug olaparib, according to new research published in #CancerCell.

Read more ⤵️

www.icr.ac.uk/news-archive...

Hi again Mehwaesh - here's the newly minted Prostate Cancer UK account to add to the pack please: bsky.app/profile/pros...

Each week my team at Prostate Cancer UK update one of our research we fund webpages. This week the work of Dr George Seed, one of our Travel Prize Fellows, had a little makeover.

#prostatecancer #research

prostatecanceruk.org/research/res...

Manchester kept its secret from me for four full years while I worked there then!

Thanks for representing us HL. A huge loss but great to see Val's achievements and character celebrated (and continued by the people she's inspired and trained).